Due to a limited supply, we are unable to accept phone calls to schedule COVID-19 vaccinations.
For the most up-to-date information, please check our COVID-19 Vaccination Website.

 

Additional Coronavirus Updates >

MENU

Fox Chase Cancer Center News

February 22, 2021

Kristen Whitaker Receives Grant From V Foundation for Cancer Research

PHILADELPHIA (February 22, 2021)—Kristen D. Whitaker, MD, MS, assistant professor in the Department of Clinical Genetics at Fox Chase Cancer Center, recently received a grant from the V Foundation for Cancer Research to study ways of improving diversity in clinical cancer trials. The grant was funded by Hooters of America, LLC.

February 19, 2021

Fox Chase Bone Marrow Transplant Department One-Year Survival Outcomes Continue to Exceed Expectations

PHILADELPHIA (February 19, 2021)—The Fox Chase-Temple University Hospital Department of Bone Marrow Transplant (BMT) and Cellular Therapies has achieved the top performance category in successful transplant procedures, making it the second year in a row that the center has earned this distinction.

February 15, 2021

Chemotherapy-Induced ‘Dormancy’ in AML Allows Cancer Cell Survival, Contributing to Relapse

PHILADELPHIA (February 15, 2021) – Researchers at Fox Chase Cancer Center have helped to identify a cellular resilience mechanism through which acute myeloid leukemia (AML) cells survive cancer treatment and repopulate leukemia, causing disease relapse. The research also suggests that certain drugs could be used to destroy these treatment-surviving AML cells.

February 2, 2021

Study Highlights How Important T Cells Are Formed and Assigned Functions

PHILADELPHIA (February 2, 2021) – New research out of Fox Chase Cancer Center has shed light on how an important type of T cell–gamma delta T cells–develop and are assigned their effector function. 

February 1, 2021

Fox Chase Cancer Center to Hold Free Virtual Symposium on Cancer Epigenetics

PHILADELPHIA (February 1, 2021)—Fox Chase Cancer Center will host a virtual symposium on cancer epigenetics on March 2 that will explore discoveries related to epigenetic mechanisms of tumorigenesis and novel therapies to better target cancer.  

January 26, 2021

Fox Chase Cancer Center Welcomes Cihangir Duy

PHILADELPHIA (January 26, 2021) – Fox Chase Cancer Center announces the hiring of Cihangir Duy, PhD, MS, who has joined the Cancer Signaling and Epigenetics Program as an assistant professor.

January 20, 2021

Elizabeth Plimack Appointed Chair of Scientific Advisory Board for Bladder Cancer Advocacy Network

PHILADELPHIA (January 19, 2021)—Elizabeth Plimack, MD, MS, professor in the Department of Hematology/Oncology and chief of the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has been appointed chair of the Scientific Advisory Board (SAB) for the Bladder Cancer Advocacy Network (BCAN).

January 11, 2021

Joel Helmke Joins Fox Chase Cancer Center as New Chief Operating Officer

PHILADELPHIA (January 11, 2021) – Fox Chase Cancer Center is pleased to announce the addition of Joel Helmke, MSHP, FACHE, to its senior leadership team as chief operating officer (COO). Helmke’s tenure will begin on February 1, 2021.

Pages

Connect with Fox Chase